Provided by Tiger Trade Technology Pte. Ltd.

ResMed

225.98
+5.292.40%
Pre-market: 227.761.78+0.79%08:52 EDT
Volume:1.13M
Turnover:255.41M
Market Cap:31.86B
PE:21.67
High:228.75
Open:222.27
Low:221.83
Close:220.69
52wk High:284.87
52wk Low:180.27
Shares:141.00M
Float Shares:140.00M
Volume Ratio:1.11
T/O Rate:0.81%
Dividend:2.40
Dividend Rate:1.06%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.84
PE(LYR):21.67

Loading ...

Jefferies Adjusts Price Target on ResMed to $225 From $240

MT Newswires Live
·
Jul 10

ResMed CEO Farrell Exercises Options and Trims Stake Under 10b5-1 Plan

TIPRANKS
·
Jul 10

Resmed Inc-statement of Changes in Beneficial Ownership

THOMSON REUTERS
·
Jul 10

Statement of Changes in Beneficial Ownership-rmd.n

Reuters
·
Jul 10

ResMed (RMD) After Russell Growth Index Exits Is The Undervalued Narrative Still Intact

Simply Wall St.
·
Jul 10

Nyxoah: Orin Hirchman-controlled Entities Disclose 14.55% Stake, Crossing 10% Threshold

Reuters
·
Jul 10

Resmed CEO Michael Farrell Sells 4,991 Shares for $1.09 Million

Reuters
·
Jul 09

Jarden Adjusts ResMed's Price Target to AU$40.20 from AU$42.70, Keeps at Overweight

MT Newswires Live
·
Jul 09

ResMed's Sale of MatrixCare Shows Willingness to Recycle Capital From Rationalizing Underperforming Units, Jarden Says

MT Newswires Live
·
Jul 09

Resmed Willing to Cut Underperforming Assets

Dow Jones
·
Jul 09

Resmed's $490M Sale Looks Strategically Sound

Dow Jones
·
Jul 09

ResMed: MatrixCare Divestiture Sharpens SaaS Growth Outlook, Supports Attractive Valuation and Reiterated Buy Rating

TIPRANKS
·
Jul 09

ResMed's $490 Million Sale of MatrixCare Not Material to Outlook, RBC Says

MT Newswires Live
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
Jul 08

Movement Alert|ResMed Falls 5.29% in Regular Trading, MatrixCare Divestiture Announcement Coupled with RBC Price Target Cut

Market Focus
·
Jul 08

RBC Capital Cuts ResMed Price Target to $276 From $321, Maintains Outperform Rating

MT Newswires Live
·
Jul 08

Resmed is Maintained at Equal-weight by Wells Fargo

Dow Jones
·
Jul 08

ResMed price target lowered to $225 from $227 at Wells Fargo

TIPRANKS
·
Jul 08

Deals of the Day-mergers and Acquisitions

Reuters
·
Jul 08

Resmed Inc : RBC Cuts Target Price to $276 from $321

THOMSON REUTERS
·
Jul 08